These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38422021)

  • 1. Structural basis for CFTR inhibition by CFTR
    Young PG; Levring J; Fiedorczuk K; Blanchard SC; Chen J
    Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2316675121. PubMed ID: 38422021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of CFTR inhibition by a thiazolidinone derivative.
    Kopeikin Z; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2010 Dec; 136(6):659-71. PubMed ID: 21078867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors.
    Melis N; Tauc M; Cougnon M; Bendahhou S; Giuliano S; Rubera I; Duranton C
    Br J Pharmacol; 2014 Aug; 171(15):3716-27. PubMed ID: 24758416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.
    Ehrhardt A; Chung WJ; Pyle LC; Wang W; Nowotarski K; Mulvihill CM; Ramjeesingh M; Hong J; Velu SE; Lewis HA; Atwell S; Aller S; Bear CE; Lukacs GL; Kirk KL; Sorscher EJ
    J Biol Chem; 2016 Jan; 291(4):1854-1865. PubMed ID: 26627831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide-releasing molecules inhibit the cystic fibrosis transmembrane conductance regulator Cl
    Rodrat M; Jantarajit W; Ng DRS; Harvey BSJ; Liu J; Wilkinson WJ; Charoenphandhu N; Sheppard DN
    Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L997-L1009. PubMed ID: 32936026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore.
    Gao X; Yeh HI; Yang Z; Fan C; Jiang F; Howard RJ; Lindahl E; Kappes JC; Hwang TC
    Nat Commun; 2024 Aug; 15(1):6668. PubMed ID: 39107303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease.
    Li H; Sheppard DN
    BioDrugs; 2009; 23(4):203-16. PubMed ID: 19697963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR function, pathology and pharmacology at single-molecule resolution.
    Levring J; Terry DS; Kilic Z; Fitzgerald G; Blanchard SC; Chen J
    Nature; 2023 Apr; 616(7957):606-614. PubMed ID: 36949202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.
    Kim Y; Anderson MO; Park J; Lee MG; Namkung W; Verkman AS
    Mol Pharmacol; 2015 Oct; 88(4):689-96. PubMed ID: 26174774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101.
    Stahl M; Stahl K; Brubacher MB; Forrest JN
    Am J Physiol Cell Physiol; 2012 Jan; 302(1):C67-76. PubMed ID: 21940661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia.
    Dong Q; Ernst SE; Ostedgaard LS; Shah VS; Ver Heul AR; Welsh MJ; Randak CO
    J Biol Chem; 2015 May; 290(22):14140-53. PubMed ID: 25887396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
    Li H; Findlay IA; Sheppard DN
    Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cystic fibrosis transmembrane conductance regulator is an extracellular chloride sensor.
    Broadbent SD; Ramjeesingh M; Bear CE; Argent BE; Linsdell P; Gray MA
    Pflugers Arch; 2015 Aug; 467(8):1783-94. PubMed ID: 25277268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
    Bompadre SG; Li M; Hwang TC
    J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Cai Z; Taddei A; Sheppard DN
    J Biol Chem; 2006 Jan; 281(4):1970-7. PubMed ID: 16311240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl
    Chen JH; Xu W; Sheppard DN
    J Physiol; 2017 Feb; 595(4):1059-1076. PubMed ID: 27779763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single conductance pore for chloride ions formed by two cystic fibrosis transmembrane conductance regulator molecules.
    Zerhusen B; Zhao J; Xie J; Davis PB; Ma J
    J Biol Chem; 1999 Mar; 274(12):7627-30. PubMed ID: 10075649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein with a Technetium-99m Imaging Probe.
    Ferreira VFC; Oliveira BL; Santos JD; Correia JDG; Farinha CM; Mendes F
    ChemMedChem; 2018 Jul; 13(14):1469-1478. PubMed ID: 29864241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
    Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
    Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.